Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-06

AUTHORS

M Bontenbal, M Andersson, J Wildiers, G Cocconi, J Jassem, R Paridaens, N Rotmensz, R Sylvester, H T Mouridsen, J G Klijn, A T van Oosterom

ABSTRACT

The EORTC Breast Cancer Cooperative Group carried out a randomized trial to compare doxorubicin with epirubicin as second-line chemotherapy in patients with metastatic breast cancer. Two hundred and fifty-nine patients with at least one site of metastatic disease entered this trial, of whom 232 patients were eligible. Treatment consisted of doxorubicin 75 mg m(-2) or epirubicin 90 mg m(-2) i.v. every 3 weeks. The overall response rates for doxorubicin and epirubicin were 36% and 28% respectively (P = 0.173). The median time to progression was 23 weeks for doxorubicin and 19 weeks for epirubicin (P = 0.063) and the median duration of response was 40 weeks for doxorubicin and 32 weeks for epirubicin (P = 0.059). The median survival was 47 weeks for doxorubicin and 44 weeks for epirubicin (P = 0.196). Leucocyte count on retreatment day (P = 0.011) and platelet nadir (P = 0.031) were significantly lower in the doxorubicin-treated group. Also mucositis (P < 0.001), diarrhoea (P = 0.005) and haemorrhage (P = 0.048) were significantly worse in the doxorubicin arm. Nine patients on doxorubicin and two patients on epirubicin experienced congestive heart failure (CHF). At the dose levels used in this study, no statistical differences in response rate and survival were found between the two treatment arms. Treatment with doxorubicin tended to result in a slightly longer duration of response and time to progression but doxorubicin was more toxic than epirubicin. More... »

PAGES

bjc1998375

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1998.375

DOI

http://dx.doi.org/10.1038/bjc.1998.375

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013763728

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9649142


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibiotics, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epirubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Erasmus University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.5645.2", 
          "name": [
            "Department of Medical Oncology, Rotterdam Cancer Institute (Dr Daniel den Hoed Kliniek), The Netherlands."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bontenbal", 
        "givenName": "M", 
        "id": "sg:person.0600257656.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600257656.02"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Andersson", 
        "givenName": "M", 
        "id": "sg:person.01103374314.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103374314.56"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Wildiers", 
        "givenName": "J", 
        "id": "sg:person.01103102326.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103102326.98"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Cocconi", 
        "givenName": "G", 
        "id": "sg:person.01170025540.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170025540.31"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Jassem", 
        "givenName": "J", 
        "id": "sg:person.0766306160.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766306160.59"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Paridaens", 
        "givenName": "R", 
        "id": "sg:person.01123442351.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123442351.24"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Rotmensz", 
        "givenName": "N", 
        "id": "sg:person.01142436535.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142436535.55"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Sylvester", 
        "givenName": "R", 
        "id": "sg:person.01363074703.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363074703.38"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Mouridsen", 
        "givenName": "H T", 
        "id": "sg:person.012473203404.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012473203404.69"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Klijn", 
        "givenName": "J G", 
        "id": "sg:person.010717707377.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010717707377.65"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "van Oosterom", 
        "givenName": "A T", 
        "id": "sg:person.0653245357.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653245357.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011360956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199102000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015677476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199102000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015677476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018717694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0305-7372(93)90036-q", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021127399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-198902000-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028285955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-198902000-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028285955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(05)80145-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034599359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198712103172402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039134108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/02841869009090012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039966774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-91-5-710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073737288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.12.2148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077930998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079759544", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079766371", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1985.3.6.818", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079997741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080435928", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1984.2.4.275", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1081839904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089168206800202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082065528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089168206800202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082065528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082281984", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.4.1146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082892979"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-06", 
    "datePublishedReg": "1998-06-01", 
    "description": "The EORTC Breast Cancer Cooperative Group carried out a randomized trial to compare doxorubicin with epirubicin as second-line chemotherapy in patients with metastatic breast cancer. Two hundred and fifty-nine patients with at least one site of metastatic disease entered this trial, of whom 232 patients were eligible. Treatment consisted of doxorubicin 75 mg m(-2) or epirubicin 90 mg m(-2) i.v. every 3 weeks. The overall response rates for doxorubicin and epirubicin were 36% and 28% respectively (P = 0.173). The median time to progression was 23 weeks for doxorubicin and 19 weeks for epirubicin (P = 0.063) and the median duration of response was 40 weeks for doxorubicin and 32 weeks for epirubicin (P = 0.059). The median survival was 47 weeks for doxorubicin and 44 weeks for epirubicin (P = 0.196). Leucocyte count on retreatment day (P = 0.011) and platelet nadir (P = 0.031) were significantly lower in the doxorubicin-treated group. Also mucositis (P < 0.001), diarrhoea (P = 0.005) and haemorrhage (P = 0.048) were significantly worse in the doxorubicin arm. Nine patients on doxorubicin and two patients on epirubicin experienced congestive heart failure (CHF). At the dose levels used in this study, no statistical differences in response rate and survival were found between the two treatment arms. Treatment with doxorubicin tended to result in a slightly longer duration of response and time to progression but doxorubicin was more toxic than epirubicin.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1998.375", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "77"
      }
    ], 
    "name": "Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer", 
    "pagination": "bjc1998375", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "41914f8861c155dd3030299a90360c4bd4ed1e17d79b17112f6ea1e19aa9e821"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9649142"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1998.375"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013763728"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1998.375", 
      "https://app.dimensions.ai/details/publication/pub.1013763728"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29203_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/bjc1998375"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1998.375'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1998.375'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1998.375'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1998.375'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      21 PREDICATES      56 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1998.375 schema:about N08e7684bdd27462ba7cb26f9c2d14595
2 N56af026f860e475594387fd81c02f334
3 N69e584d5624045bc946359a41c6b0b7a
4 N94ea555329924bc09d36b52db6c867bc
5 Na4270f60b0df43b383b9608bccc18b39
6 Ncf85f24734174e1cb710830747277cc6
7 Ne8ca6181a6ef41aa9565434c22643e17
8 Nf3e310cbc74949f99dd1f75b916cc56f
9 Nf689e610a49e414da2f711fda127623b
10 anzsrc-for:11
11 anzsrc-for:1112
12 schema:author N9234dba156c44fa2996bcd7124c3b202
13 schema:citation https://app.dimensions.ai/details/publication/pub.1079759544
14 https://app.dimensions.ai/details/publication/pub.1079766371
15 https://app.dimensions.ai/details/publication/pub.1080435928
16 https://app.dimensions.ai/details/publication/pub.1082281984
17 https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5
18 https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f
19 https://doi.org/10.1016/0305-7372(93)90036-q
20 https://doi.org/10.1016/s0959-8049(05)80145-5
21 https://doi.org/10.1056/nejm198712103172402
22 https://doi.org/10.1097/00000421-198902000-00014
23 https://doi.org/10.1097/00000421-199102000-00009
24 https://doi.org/10.1177/030089168206800202
25 https://doi.org/10.1200/jco.1984.2.4.275
26 https://doi.org/10.1200/jco.1985.3.6.818
27 https://doi.org/10.1200/jco.1991.9.12.2148
28 https://doi.org/10.1200/jco.1996.14.4.1146
29 https://doi.org/10.3109/02841869009090012
30 https://doi.org/10.7326/0003-4819-91-5-710
31 schema:datePublished 1998-06
32 schema:datePublishedReg 1998-06-01
33 schema:description The EORTC Breast Cancer Cooperative Group carried out a randomized trial to compare doxorubicin with epirubicin as second-line chemotherapy in patients with metastatic breast cancer. Two hundred and fifty-nine patients with at least one site of metastatic disease entered this trial, of whom 232 patients were eligible. Treatment consisted of doxorubicin 75 mg m(-2) or epirubicin 90 mg m(-2) i.v. every 3 weeks. The overall response rates for doxorubicin and epirubicin were 36% and 28% respectively (P = 0.173). The median time to progression was 23 weeks for doxorubicin and 19 weeks for epirubicin (P = 0.063) and the median duration of response was 40 weeks for doxorubicin and 32 weeks for epirubicin (P = 0.059). The median survival was 47 weeks for doxorubicin and 44 weeks for epirubicin (P = 0.196). Leucocyte count on retreatment day (P = 0.011) and platelet nadir (P = 0.031) were significantly lower in the doxorubicin-treated group. Also mucositis (P < 0.001), diarrhoea (P = 0.005) and haemorrhage (P = 0.048) were significantly worse in the doxorubicin arm. Nine patients on doxorubicin and two patients on epirubicin experienced congestive heart failure (CHF). At the dose levels used in this study, no statistical differences in response rate and survival were found between the two treatment arms. Treatment with doxorubicin tended to result in a slightly longer duration of response and time to progression but doxorubicin was more toxic than epirubicin.
34 schema:genre research_article
35 schema:inLanguage en
36 schema:isAccessibleForFree true
37 schema:isPartOf N17dac22263a94dd0856c42529d0cf9f0
38 Nb0a48e5a34074faa8e4a0300f5dcf1fe
39 sg:journal.1017082
40 schema:name Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer
41 schema:pagination bjc1998375
42 schema:productId N2083133c8cec41f89b9b1f0ba56c7c32
43 Ncd99ac33680948ec94864791871c934a
44 Nd2a04e5109b546aa8d2b7c2bf1c5f3fd
45 Nd650d7f79103463f9a568c74f0a31191
46 Ne423ccfa218043e18c1ba09d522efd1f
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013763728
48 https://doi.org/10.1038/bjc.1998.375
49 schema:sdDatePublished 2019-04-11T11:54
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher Nd17a3695c32f4f52a2ad08e2af428b23
52 schema:url http://www.nature.com/articles/bjc1998375
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N08e7684bdd27462ba7cb26f9c2d14595 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Doxorubicin
58 rdf:type schema:DefinedTerm
59 N0fa7e3c1d7df47f8a3d9e16e211b6d06 rdf:first sg:person.01363074703.38
60 rdf:rest Nbcbc2890f6bd43c0856b30651174bc79
61 N1725e3ae729442bd88f3847df8ca92ba rdf:first sg:person.01142436535.55
62 rdf:rest N0fa7e3c1d7df47f8a3d9e16e211b6d06
63 N17dac22263a94dd0856c42529d0cf9f0 schema:issueNumber 12
64 rdf:type schema:PublicationIssue
65 N2083133c8cec41f89b9b1f0ba56c7c32 schema:name nlm_unique_id
66 schema:value 0370635
67 rdf:type schema:PropertyValue
68 N406396add6954cfebabb918b89729d7e rdf:first sg:person.01123442351.24
69 rdf:rest N1725e3ae729442bd88f3847df8ca92ba
70 N56af026f860e475594387fd81c02f334 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Middle Aged
72 rdf:type schema:DefinedTerm
73 N5d54fb06c4ca40bf9e55f6b9adbca05e rdf:first sg:person.01103374314.56
74 rdf:rest N66c5df88e43e4421877a653586512347
75 N66c5df88e43e4421877a653586512347 rdf:first sg:person.01103102326.98
76 rdf:rest Nb693fc9e81744d76a61b88893f3ead41
77 N69e584d5624045bc946359a41c6b0b7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Breast Neoplasms
79 rdf:type schema:DefinedTerm
80 N9234dba156c44fa2996bcd7124c3b202 rdf:first sg:person.0600257656.02
81 rdf:rest N5d54fb06c4ca40bf9e55f6b9adbca05e
82 N94ea555329924bc09d36b52db6c867bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Humans
84 rdf:type schema:DefinedTerm
85 Na4270f60b0df43b383b9608bccc18b39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Female
87 rdf:type schema:DefinedTerm
88 Nb0a48e5a34074faa8e4a0300f5dcf1fe schema:volumeNumber 77
89 rdf:type schema:PublicationVolume
90 Nb35f3684f91945b6ae6d710b2b99fa6d rdf:first sg:person.010717707377.65
91 rdf:rest Ne54024bbf27b42dcac4003a7432ea529
92 Nb693fc9e81744d76a61b88893f3ead41 rdf:first sg:person.01170025540.31
93 rdf:rest Nee2aeb644b8342bca29d71a171c7f57e
94 Nbcbc2890f6bd43c0856b30651174bc79 rdf:first sg:person.012473203404.69
95 rdf:rest Nb35f3684f91945b6ae6d710b2b99fa6d
96 Ncd99ac33680948ec94864791871c934a schema:name dimensions_id
97 schema:value pub.1013763728
98 rdf:type schema:PropertyValue
99 Ncf85f24734174e1cb710830747277cc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adult
101 rdf:type schema:DefinedTerm
102 Nd17a3695c32f4f52a2ad08e2af428b23 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 Nd2a04e5109b546aa8d2b7c2bf1c5f3fd schema:name pubmed_id
105 schema:value 9649142
106 rdf:type schema:PropertyValue
107 Nd650d7f79103463f9a568c74f0a31191 schema:name doi
108 schema:value 10.1038/bjc.1998.375
109 rdf:type schema:PropertyValue
110 Ne423ccfa218043e18c1ba09d522efd1f schema:name readcube_id
111 schema:value 41914f8861c155dd3030299a90360c4bd4ed1e17d79b17112f6ea1e19aa9e821
112 rdf:type schema:PropertyValue
113 Ne54024bbf27b42dcac4003a7432ea529 rdf:first sg:person.0653245357.14
114 rdf:rest rdf:nil
115 Ne8ca6181a6ef41aa9565434c22643e17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Epirubicin
117 rdf:type schema:DefinedTerm
118 Nee2aeb644b8342bca29d71a171c7f57e rdf:first sg:person.0766306160.59
119 rdf:rest N406396add6954cfebabb918b89729d7e
120 Nf3e310cbc74949f99dd1f75b916cc56f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Aged
122 rdf:type schema:DefinedTerm
123 Nf689e610a49e414da2f711fda127623b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Antibiotics, Antineoplastic
125 rdf:type schema:DefinedTerm
126 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
127 schema:name Medical and Health Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
130 schema:name Oncology and Carcinogenesis
131 rdf:type schema:DefinedTerm
132 sg:journal.1017082 schema:issn 0007-0920
133 1532-1827
134 schema:name British Journal of Cancer
135 rdf:type schema:Periodical
136 sg:person.010717707377.65 schema:familyName Klijn
137 schema:givenName J G
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010717707377.65
139 rdf:type schema:Person
140 sg:person.01103102326.98 schema:familyName Wildiers
141 schema:givenName J
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103102326.98
143 rdf:type schema:Person
144 sg:person.01103374314.56 schema:familyName Andersson
145 schema:givenName M
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103374314.56
147 rdf:type schema:Person
148 sg:person.01123442351.24 schema:familyName Paridaens
149 schema:givenName R
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123442351.24
151 rdf:type schema:Person
152 sg:person.01142436535.55 schema:familyName Rotmensz
153 schema:givenName N
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142436535.55
155 rdf:type schema:Person
156 sg:person.01170025540.31 schema:familyName Cocconi
157 schema:givenName G
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170025540.31
159 rdf:type schema:Person
160 sg:person.012473203404.69 schema:familyName Mouridsen
161 schema:givenName H T
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012473203404.69
163 rdf:type schema:Person
164 sg:person.01363074703.38 schema:familyName Sylvester
165 schema:givenName R
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363074703.38
167 rdf:type schema:Person
168 sg:person.0600257656.02 schema:affiliation https://www.grid.ac/institutes/grid.5645.2
169 schema:familyName Bontenbal
170 schema:givenName M
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600257656.02
172 rdf:type schema:Person
173 sg:person.0653245357.14 schema:familyName van Oosterom
174 schema:givenName A T
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653245357.14
176 rdf:type schema:Person
177 sg:person.0766306160.59 schema:familyName Jassem
178 schema:givenName J
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766306160.59
180 rdf:type schema:Person
181 https://app.dimensions.ai/details/publication/pub.1079759544 schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1079766371 schema:CreativeWork
183 https://app.dimensions.ai/details/publication/pub.1080435928 schema:CreativeWork
184 https://app.dimensions.ai/details/publication/pub.1082281984 schema:CreativeWork
185 https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018717694
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1011360956
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/0305-7372(93)90036-q schema:sameAs https://app.dimensions.ai/details/publication/pub.1021127399
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s0959-8049(05)80145-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034599359
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1056/nejm198712103172402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039134108
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1097/00000421-198902000-00014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028285955
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1097/00000421-199102000-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015677476
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1177/030089168206800202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082065528
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1200/jco.1984.2.4.275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1081839904
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1200/jco.1985.3.6.818 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079997741
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1200/jco.1991.9.12.2148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077930998
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1200/jco.1996.14.4.1146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082892979
208 rdf:type schema:CreativeWork
209 https://doi.org/10.3109/02841869009090012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039966774
210 rdf:type schema:CreativeWork
211 https://doi.org/10.7326/0003-4819-91-5-710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073737288
212 rdf:type schema:CreativeWork
213 https://www.grid.ac/institutes/grid.5645.2 schema:alternateName Erasmus University Medical Center
214 schema:name Department of Medical Oncology, Rotterdam Cancer Institute (Dr Daniel den Hoed Kliniek), The Netherlands.
215 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...